Zobrazeno 1 - 2
of 2
pro vyhledávání: '"M. T. Latancia"'
Autor:
I. de Souza, L. K. S. Monteiro, C. B. Guedes, M. M. Silva, M. Andrade-Tomaz, B. Contieri, M. T. Latancia, D. Mendes, B. F. M. M. Porchia, M. Lazarini, L. R. Gomes, C. R. R. Rocha
Publikováno v:
Cell Death and Disease, Vol 13, Iss 7, Pp 1-13 (2022)
Abstract Glioblastoma patients have a poor prognosis mainly due to temozolomide (TMZ) resistance. NRF2 is an important transcript factor involved in chemotherapy resistance due to its protective role in the transcription of genes involved in cellular
Externí odkaz:
https://doaj.org/article/1e66b1827a5d4c4490fa290aacdc9ede
Autor:
I. de Souza, L. K. S. Monteiro, C. B. Guedes, M. M. Silva, M. Andrade-Tomaz, B. Contieri, M. T. Latancia, D. Mendes, B. F. M. M. Porchia, M. Lazarini, L. R. Gomes, C. R. R. Rocha
Publikováno v:
Cell deathdisease. 13(7)
Glioblastoma patients have a poor prognosis mainly due to temozolomide (TMZ) resistance. NRF2 is an important transcript factor involved in chemotherapy resistance due to its protective role in the transcription of genes involved in cellular detoxifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3979412ae454a8b12e4abd420675fe82
https://pubmed.ncbi.nlm.nih.gov/35803910
https://pubmed.ncbi.nlm.nih.gov/35803910